• Oxford Community Paramedicine Remote Patient Monitoring (CPRPM) Referral Form: Supports moderate to severe chronic disease patients and frequent users of 911 self-manage their conditions through regular monitoring of vitals & health coaching at home for up to 90-days.

• Memo- Infant and high risk children RSV prevention program
• Guidance for Health Care Providers – Beyfortus®
• Guidance for Health Care Providers – AbrysvoTM
• Covid-19 Guidance: Primary Care 
• Memo – Recommendation on the use of Paxlovid  / Note de service – Recommandation sur l’utilisation de Paxlovid
• Memo – Updated recommendation on the use of Evusheld /Note de service – Mise à jour des recommandations sur l’utilisation d’Evusheld

• Ontario Structured Psychotherapy provides support for adults with depression, anxiety, and anxiety-related concerns.  Treatments may combine self-led strategies with support from a coach by telephone, or structured group or one-on-one therapy, virtually or in person. For referral information for Care Providers, visit www.ospwest.ca/care-providers
• Respiratory Syncytial Virus (RSV) Fact Sheet
• Respiratory Syncytial Virus (RSV) Prevention Program – Immunity, Monoclonal Antibodies and Vaccination
• Respiratory Syncytial Virus (RSV) Prevention Program – Monoclonal Antibody for Infants and High-risk Children
• Respiratory Syncytial Virus (RSV) Prevention Program – Vaccine for Pregnant Individuals

• Paxlovid Prescription Form and Paxlovid Eligibility EMR Search (Telus PS Suite, OSCAR and Accuro) – search four different ways for specific patients that are eligible for Paxlovid.

From March 31, 2023 – December 29, 2023, Ontario Drug Benefit (ODB) recipients who are on an originator biologic will begin to transition to a Health Canada approved biosimilar version of the drug at no cost.

• Lantus® LU codes will be phased out on December 29^th, 2023.
• There are now TWO biosimilars for insulin glargine: Semglee® and Basaglar^TM.
• Insulin brand must now be specified on a prescription.
• Pharmacists are not allowed to select or substitute insulin brand.
• The billing code K900A (biosimilar support: $61.20) supports these efforts.

The Centre for Effective Practice is offering free 1-on-1, individualized best practice discussions (academic detailing) to help support timely strategies for identifying and preparing patients for the upcoming switch in funding to reduce the chance of insulin therapy interruptions. These sessions are Mainpro+ accredited.

Book Now!

• Sites supported by Thames Valley Family Health Team: Contact your FHT pharmacist to book
• Sites not supported by Thames Valley FHT:
  • Academic detailing pharmacist is Nicole Seymour
  • Book a virtual visit: https://cepnicole.timetap.com/#/
  • Book a virtual or in person visit:
    • email: seymour@cep.health
    • cell: 519-619-1180

We have compiled these resources from various sources to support you and your staff to prepare for respiratory virus season and to help educate your patients.

Clinician Resources:

Patient-Public Resources: